US 8,912,335 B2 · PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Abstract

The present invention relates to novel salts of thiazolidinediones and other pharmaceutical agents that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease).

Claims1

Dependent claims

A sodium salt of a compound having the structure:

Dependencies are inferred from the claim text.

Facts

Application

13/515,508Filed 15 Dec 2010 · us provisional application

Priority

15 Dec 2009

Published

US 2012/0309975 A16 Dec 2012

Granted

16 Dec 2014

Term ends

Not estimatedThe source records don’t support an estimate.

Classification10 codes

C07D 277/34
With hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals,…:…
A61P 3/00
Drugs for disorders of the metabolism
A61P 3/04
Drugs for disorders of the metabolism: anorexiants; Antiobesity agents
A61P 3/10
For glucose homeostasis: for hyperglycaemia, e.g. antidiabetics

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Life of this patent

Abstract

Claims1

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

Life of this patent

Abstract

Claims1